These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9698677)

  • 41. Proliferative and lymphoid reactions in bladder cancer.
    Sarma KP
    Invest Urol; 1972 Nov; 10(3):199-207. PubMed ID: 4640489
    [No Abstract]   [Full Text] [Related]  

  • 42. Neoplasms in bladder diverticula.
    Siegel WH
    Urology; 1974 Oct; 4(4):411-3. PubMed ID: 4214048
    [No Abstract]   [Full Text] [Related]  

  • 43. [Neuroendocrine cell carcinoma of the urinary bladder: a case report].
    Mikami K; Ito H; Masai M; Kotake T; Sugano I; Nagao K
    Hinyokika Kiyo; 1996 Jul; 42(7):529-31. PubMed ID: 8809564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Kodamaea ohmeri: fungemia in a patient with invasive bladder cancer].
    de Miguel-Martinez I; Carrillo-Quintero D; Cano-Lira JF; Ojeda-Vargas M
    Enferm Infecc Microbiol Clin; 2013 Nov; 31(9):633-4. PubMed ID: 23608203
    [No Abstract]   [Full Text] [Related]  

  • 45. Urothelial carcinoma with plasmocytoid component.
    Kourda N; Bouzouita A; Azouz H; Derouiche A; Blel A; Chebil M; Ben Jilani SB; Zermani R
    Pathologica; 2009 Dec; 101(6):253-4. PubMed ID: 20387714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Small cell carcinoma of the urinary bladder: a case report].
    Koroku M; Tanda H; Katoh S; Onishi S; Nakajima H; Nanbu A; Nitta T; Akagashi K
    Hinyokika Kiyo; 2001 Oct; 47(10):743-5. PubMed ID: 11758359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The problem of urinary bladder cancer--an attempt at a therapeutic standard].
    Langkopf B; Hofmann W
    Z Urol Nephrol; 1987 Nov; 80(11):647-51. PubMed ID: 2449781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Urothelial neoplasia as a late complication of transitional-cell carcinoma of the bladder].
    Petta S; Bilotta L; Pacchiele R; Palleschi G; Aloisi P
    Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):55-8. PubMed ID: 9707773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal infarction secondary to infiltrative transitional cell carcinoma.
    Castle EP; Blackford T; Langenstroer P
    J Urol; 2004 Aug; 172(2):477. PubMed ID: 15247707
    [No Abstract]   [Full Text] [Related]  

  • 50. Fibrosarcoma arising in diverticulum of the urinary bladder.
    Doctor VM; Karanjavala DK
    Br J Urol; 1975 Apr; 47(2):184. PubMed ID: 807282
    [No Abstract]   [Full Text] [Related]  

  • 51. Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma.
    Tai YS; Chen CH; Huang CY; Tai HC; Wang SM; Pu YS
    Diabetes Metab Res Rev; 2015 Mar; 31(3):307-14. PubMed ID: 25363092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Radical cystectomy in the treatment of invasive bladder cancer].
    Shaplygin LV; Sitnikov NV; Furashov DV; Dronov VI; Deviatov AS; Sidorov VA
    Voen Med Zh; 2003 Dec; 324(12):43-6. PubMed ID: 14982004
    [No Abstract]   [Full Text] [Related]  

  • 53. Transitional cell carcinoma of the bladder in a patient on clean intermittent catheterization.
    Gana BM; Aniah M; Taube M
    BJU Int; 2000 Jan; 85(1):171. PubMed ID: 10691345
    [No Abstract]   [Full Text] [Related]  

  • 54. [Solid tumor in terminal phase: interpretation of biologic anomalies (hematologic tests)].
    Salignac S; Walter A; Feugier P; Lecompte T; Lesesve JF
    Ann Biol Clin (Paris); 2002; 60(1):96-100. PubMed ID: 11830400
    [No Abstract]   [Full Text] [Related]  

  • 55. Current perspectives in the management of high-grade invasive bladder cancer.
    Skinner DG
    Cancer; 1980 Apr; 45(7 Suppl):1866-74. PubMed ID: 7370937
    [No Abstract]   [Full Text] [Related]  

  • 56. Tumor-associated tissue eosinophilia and inflammation in pTa and pT1 papillary urothelial carcinoma of the bladder.
    Marusić Z; Cupić H; Kruslin B; Tomas D; Milosević M; Mikuz G
    Anal Quant Cytol Histol; 2009 Aug; 31(4):239-41. PubMed ID: 19736872
    [No Abstract]   [Full Text] [Related]  

  • 57. [Diagnosis and substaging of pT1 bladder cancer].
    Cheng L; Huang WB; Zheng SQ; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):636-9. PubMed ID: 18070458
    [No Abstract]   [Full Text] [Related]  

  • 58. [Distant Metastasis in Patients with Non-Muscle Invasive Bladder Cancer without Local Recurrence : Report of Two Rare Cases].
    Kida K; Shimizu Y; Ogawa K; Kanamaru S; Ito N
    Hinyokika Kiyo; 2018 Jun; 64(6):271-275. PubMed ID: 30064166
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Re: an interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma.
    Chahal R; Harrison SC
    J Urol; 2003 Oct; 170(4 Pt 1):1327; author reply 1327. PubMed ID: 14515867
    [No Abstract]   [Full Text] [Related]  

  • 60. Re: an interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma.
    Erickson D; Kunselman A; Bentley C
    J Urol; 2003 Oct; 170(4 Pt 1):1326-7; author reply 1327. PubMed ID: 14501760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.